Dr Jennifer Heaney
Supervisor Details
Research Interests
Jennifer’s research has three core areas of focus, which often intersect:
- Immunoassay design, development, and validation.
- Myeloma biology.
- Basic immunology research with an emphasis on oral immunity.
Jennifer is passionate about developing testing solutions that are low-cost and straightforward to remove obstacles to achieving patient benefits and to improve access to testing. She collaborates with industry partners to develop and manufacture tests.
She is currently working on a rapid test to help tackle diagnostic delay in myeloma and improve access to myeloma testing in low-middle income countries. This work is being supported by CRUK.
Her other ongoing immunoassay projects include: validating a new sensitive laboratory method for detecting and monitoring low-level myeloma disease, rapid testing to assess protection against disease to inform vaccination, and high sensitivity non-invasive testing for applications in multiple sclerosis.
Alongside immunoassay development, Jennifer continues research into myeloma biology, namely immunosuppression in myeloma, and oral immunity. She is particularly interested in differences between oral and systemic immunity and is investigating this theme in both health and disease.
MIBTP Project Details
Dr Jennifer Heaney is supervising no projects this year.